Nicardipine

Half-Life (t½)
PO: 3h · IV: 3h
Formula
C26H29N3O6
Molecular Weight
479.53 g/mol
PubChem CID
4474
Aliases
Cardene

Pharmacological Mechanism

Dihydropyridine CCB — vascular Cav1.2 selectivity. IV continuous infusion form for hypertensive emergencies + intraoperative HTN. Less reflex tachycardia than IR nifedipine.

Half-Life & Elimination Curve (PO: 3h · IV: 3h)

100%50%25%12.5%0%0h0×t½3h1×t½6h2×t½9h3×t½12h4×t½15h5×t½0×t½ (0h): 100% remaining (~10.7 µg/L)1×t½ (3h): 50% remaining (~5.34 µg/L)2×t½ (6h): 25% remaining (~2.67 µg/L)3×t½ (9h): 12.5% remaining (~1.33 µg/L)4×t½ (12h): 6.3% remaining (~0.667 µg/L)5×t½ (15h): 3.1% remaining (~0.333 µg/L)
Plasma (PO)t½ Decay (3h)Effect Site (ke0)
  • 0×t½0h100% (10.7 µg/L)
  • 1×t½3h50% (5.34 µg/L)
  • 2×t½6h25% (2.67 µg/L)
  • 3×t½9h12.5% (1.33 µg/L)
  • 4×t½12h6.3% (0.667 µg/L)
  • 5×t½15h3.1% (0.333 µg/L)
Elimination t½3h (PO)
Rate Constant (ke)0.231 h⁻¹
Time to Peak (Tmax)1.47h
Est. Peak (Cmax)10.7 µg/L
Clearance (CL)139 L/h
97% Washout (5×t½)15h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References